A comparison of metacognitive factors among patients with cancer and the control group
| Autor: | Mahmut Gumus, Hasan Mutlu, F. Isil Bilican, Hacer Hicran Mutlu |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Oncology
Adult Male 050103 clinical psychology medicine.medical_specialty medicine.medical_treatment Locally advanced Metacognition Experimental and Cognitive Psychology Anxiety 03 medical and health sciences 0302 clinical medicine Cognition Internal medicine Neoplasms Surveys and Questionnaires Psychological support medicine Humans 0501 psychology and cognitive sciences Stage (cooking) MUTLU H. H. Bilican F. I. Mutlu H. H. Gumus M. -A comparison of metacognitive factors among patients with cancer and the control group- PSYCHO-ONCOLOGY cilt.27 ss.1277-1283 2018 Chemotherapy business.industry 05 social sciences Cancer Middle Aged medicine.disease Control Groups Radiation therapy Psychiatry and Mental health Treatment modality 030220 oncology & carcinogenesis Female business |
| Zdroj: | Psycho-oncology. 27(4) |
| ISSN: | 1099-1611 |
| Popis: | Objective Research examining the relationship between metacognitions and cancer has only recently begun to emerge. This study attempted to compare the metacognitions of the patients with and without cancer. The effects of stage of cancer, type of cancer, and treatment modality (chemotherapy, radiotherapy, operation) on metacognitions were investigated. Patients with cancer were hypothesized to have higher levels of negative metacognitions. Methods Participants were patients with cancer (N = 279) and patients without cancer (control group, N = 212). The Metacognition Questionnaire-30 was administered to all participants. Results were analyzed according to demographic and histopathological characteristics of the patients. Results The results showed that patients with different cancer diagnoses scored higher than the controls on all subscales of the MCQ-30. Those who received chemotherapy scored the highest on the MCQ-30. The patients who were in early stages of cancer had higher levels of negative metacognitions. Patients who did not have operation but had chemotherapy had the highest levels of negative metacognitions. Patients who were in locally advanced stage, did not have operation but had received or was receiving chemotherapy had the highest levels of negative metacognitions. Conclusions Patients who were in early stages of cancer appeared to be in greater need for psychological help and access to services. Findings indicated a need for psychological support for patients who undergo chemotherapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text